Novartis Beats Subpoenas In Jaw-Injuries Drug Suit

Law360, New York (September 17, 2013, 2:37 PM EDT) -- A Florida federal judge last week refused to permit the subpoena of two Novartis Pharmaceuticals Corp. employees, in a lawsuit concerning jaw injuries allegedly caused by the bone drugs Aredia and Zometa, saying the employees are too far from the trial location.

Plaintiff Ruth Dopson-Troutt was diagnosed with breast cancer, which later metastasized to her hip and pelvic bones, and her oncologist prescribed Aredia and Zometa from 1999 to 2005. But after Dopson-Troutt had a tooth extracted, she began experiencing jaw pain caused by osteonecrosis of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Dopson-Troutt et al v. Novartis Pharmaceuticals Corporation


Case Number

8:06-cv-01708

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Susan C Bucklew

Date Filed

September 15, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.